BostonGene Liquid Biopsy

Minimally invasive tumor profiling from a standard blood sample

Verified partnerTakes insuranceFinancial aid availableFeatured

Testing

Your records go with you, in one click

Comprehensive molecular and immune tumor profiling to guide precision treatment. OpenCancer pre-fills the BostonGene intake from your records and carries your consent, so nothing gets retyped and nothing moves without your say-so.

Why BostonGene exists

BostonGene Liquid Biopsy profiles your tumor from a standard blood draw, sequencing both cfDNA and cfRNA to identify clinically relevant gene alterations (SNVs, indels, and gene rearrangements) and predictive gene-expression signatures. It supports treatment-response monitoring, residual-disease monitoring, and general tumor profiling, without a tissue biopsy.

Blood draw; no tissue biopsy needed

1
A standard blood draw
No tissue biopsy needed: the test runs from a routine blood sample.
2
cfDNA + cfRNA sequencing
Both DNA and RNA in the blood are sequenced for a fuller molecular picture.
3
Biomarkers identified
Clinically relevant alterations and gene-expression signatures are surfaced.
4
Monitor over time
Repeat draws track treatment response and residual disease.

Prefer the source? BostonGene Liquid Biopsy's own site has more.

Connect with BostonGene via OpenCancer

Direct intake integration: your records, case summary, and consent flow to BostonGene in one step — nothing retyped, nothing sent without your sign-off.

Connect now →

Check your coverage

See if your insurance covers this and estimate out-of-pocket cost.

Check coverage →

Coverage, insurance & cost

The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how BostonGene Liquid Biopsy handles billing.

Insurance

Accepted

Financial aid

Available

Prior auth

Required

In-network carriers

MedicareBlue Cross Blue ShieldUnitedHealthcareAetna

Build a personalized cost estimate

Ask about this service

Answers grounded in BostonGene's details here. Educational only; your oncologist directs treatment.

Who this is for

Cancer types served

bladderbrainbreastcolorectalesophagealgastricleukemialunglymphomamelanomaovarianpancreaticprostatesarcomasolid tumors

Most relevant with

EGFRKRASALKBRAFHER2

Sample: A standard blood draw.

How to ask your doctor about this

Questions to bring to your oncologist. This page is general information, not medical advice.

Could a blood-based test profile my tumor without another biopsy?
Would cfDNA/cfRNA sequencing add anything to my current testing?
Can we use this to monitor whether my treatment is working over time?

Common questions in this category

Based on what other patients have asked.

When is a pet/ct scan advised for a new breast cancer diagnosis

Breast Cancer

Does the specific variant of the CHEk2 mutation make a difference? I have the Ashkenazi Founder variant.

Is the CHEK2 mutation related to prostate cancer

What lifestyle changes are recommended for Prostate - Early Stage patients

Prostate - Early Stage

What should I know as a newly diagnosed CRC patient

Colorectal Cancer

What should I ask my oncologist after a new diagnosis

Also consider

Other providers in similar categories.

BostonGene

5 offerings

Target immunotherapies with the highest likelihood of response

Tempus

5 offerings

Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.

Foundation Medicine

4 offerings

FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.